Active Ingredient(s): Cefoxitin
FDA Approved: * October 18, 1978
Pharm Company: * MERCK
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Mefoxin Overview

Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. It was synthesized in order to create an antibiotic with a broader spectrum.[3] It is often grouped with the second-generation cephalosporins.[4] Cefoxitin requires a prescription and as of 2010 is sold under the brand name Mefoxin by Bioniche Pharma, LLC. The generic version of cefoxitin is known as cefoxitin so...

Read more Mefoxin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Mefoxin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 10g, 10gm/vial, 1g, 1g/50ml, 1gm/vial, 2g, 2g/50ml, 2gm/2vial + 2gm/vial, 2gm/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mefoxin: (2 results)

Sorted by National Drug Code
  • 67457-189 Mefoxin 1 g/50ml Intravenous Injection, Solution by Bioniche Pharma USA LLC
  • 67457-216 Mefoxin 2 g/50ml Intravenous Injection, Solution by Bioniche Pharma USA LLC

Other drugs which contain Cefoxitin or a similar ingredient: (1 result)